Matches in Wikidata for { <http://www.wikidata.org/entity/Q91166911> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q91166911 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q91166911 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91166911 description "scientific article published on 26 October 2018" @default.
- Q91166911 description "wetenschappelijk artikel" @default.
- Q91166911 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q91166911 name "Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91166911 name "Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91166911 type Item @default.
- Q91166911 label "Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91166911 label "Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91166911 prefLabel "Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91166911 prefLabel "Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91166911 P1433 Q91166911-FBF77747-DBFA-45E2-9234-C507E55D043E @default.
- Q91166911 P1476 Q91166911-83D3331F-2D8F-4A95-B02C-A0607149D3AD @default.
- Q91166911 P2093 Q91166911-3266AEF3-EA8D-48B7-BBE8-EEA0C8B5188A @default.
- Q91166911 P2093 Q91166911-D313CE4D-4DEB-4414-AA03-5F2A9FCE7973 @default.
- Q91166911 P304 Q91166911-37FD09AD-A1E6-4C0D-A33A-B9758CDC1BD5 @default.
- Q91166911 P31 Q91166911-501AF4F1-93EB-4094-978E-68772DCD992D @default.
- Q91166911 P356 Q91166911-385A1BB6-7648-469B-8CC5-6062A3E661D1 @default.
- Q91166911 P433 Q91166911-A47639A4-6BAE-4FB9-B0A4-8841BD25E88B @default.
- Q91166911 P478 Q91166911-4094ACF7-E1ED-4499-B7B0-4EF16B927D20 @default.
- Q91166911 P577 Q91166911-8BD40777-EE9A-4670-B1EA-5DC00AE3C7B3 @default.
- Q91166911 P698 Q91166911-610987E9-5D5B-4A97-B189-4A60910447AC @default.
- Q91166911 P921 Q91166911-2E26784C-B235-4C98-9082-C2C0CDF79DF1 @default.
- Q91166911 P921 Q91166911-50CD19B1-BD3C-42D1-990E-6C8EDC5D84C8 @default.
- Q91166911 P356 J.EURURO.2018.10.030 @default.
- Q91166911 P698 30670365 @default.
- Q91166911 P1433 Q15763991 @default.
- Q91166911 P1476 "Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91166911 P2093 "Pirus Ghadjar" @default.
- Q91166911 P2093 "Thomas Wiegel" @default.
- Q91166911 P304 "e61-e62" @default.
- Q91166911 P31 Q13442814 @default.
- Q91166911 P356 "10.1016/J.EURURO.2018.10.030" @default.
- Q91166911 P433 "3" @default.
- Q91166911 P478 "75" @default.
- Q91166911 P577 "2018-10-26T00:00:00Z" @default.
- Q91166911 P698 "30670365" @default.
- Q91166911 P921 Q1640214 @default.
- Q91166911 P921 Q42824827 @default.